Laval Chan Chun Kong

This inventor holds 26 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Antiviral Compounds. Top assignees: Viro Chem Pharma, Inc., Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (Canada) Incorporated. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laval Chan Chun Kong. Retrieved from https://idiyas.com/inventor/laval-chan-chun-kong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 12)

% Patents Active = 7.7

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 15)

Average Co-Inventor Count = 7.4

ph-index = 7

Forward Citations = 220(Granted Patents)

Location History:

Quebec, CA (2012)
Kirkland, CA (2001 - 2014)

Company Filing History:

11 out of 11

Viro Chem Pharma, Inc.

patents

8 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

6 out of 6

Vertex Pharmaceuticals (Canada) Incorporated

Years Active: 2001-2014

Loading Chart...

Areas of Expertise:

Flavivirus

Spirotropane

Benzimidazole

Thiophene

HIV

Antiviral

Chemokine Receptor

Lupane Derivatives

Nucleotide Analogs

Modulation

Compounds

Methods

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8829030 - [object Object] (2014-09-09),

2. 8779156 - Analogues for the treatment or prevention of flavivirus infections (2014-07-15),

3. 8765731 - Benzimidazole analogues for the treatment or prevention of flavivirus infections (2014-07-01),

4. 8674118 - Compounds and methods for the treatment or prevention of flavivirus infections (2014-03-18),

5. 8658674 - Thiophene analogues for the treatment or prevention of flavivirus infections (2014-02-25),

6. 8431556 - C-21-keto lupane derivatives preparation and use thereof (2013-04-30),

7. 8357718 - Compounds and methods for the treatment or prevention of flavivirus infections (2013-01-22),

8. 8354419 - Benzimidazole analogues for the treatment or prevention of flavivirus infections (2013-01-15),

9. 8329924 - [object Object] (2012-12-11),

10. 8269026 - Lupane derivatives useful for treating HIV (2012-09-18),

11. 8269014 - Thiophene analogues for the treatment or prevention of flavivirus infections (2012-09-18),

12. 8158675 - [object Object] (2012-04-17),

13. 8124613 - Spirotropane compounds (2012-02-28),

14. 8076349 - Spirotropane compounds and methods for the modulation of chemokine receptor activity (2011-12-13),

15. 8003685 - Thiophene analogues for the treatment or prevention of flavivirus infections (2011-08-23),

Title: Inventor Profile - Laval Chan Chun Kong

Introduction: Laval Chan Chun Kong is a renowned inventor based in Kirkland, California. He is known for his innovative contributions in various fields of technology and engineering.

Latest Patents: Laval Chan Chun Kong holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation. His recent patents focus on enhancing the efficiency of solar panels and developing smart grid solutions.

Career Highlights: With a background in electrical engineering, Laval Chan Chun Kong has had a successful career working for leading tech companies in Silicon Valley. He has been instrumental in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Laval Chan Chun Kong has collaborated with top researchers, engineers, and scientists to bring his inventions to life. His collaborative efforts have led to groundbreaking innovations that have had a significant impact on the tech sector.

Conclusion: Laval Chan Chun Kong's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His work continues to inspire the next generation of innovators to think creatively and drive positive change through their inventions.

Profile summary based on public USPTO records.